Explore the frontier
Filter every story, video, company, game and lab experiment by topic, disease area, technology, company, development stage, format and audience.
18 results · 1 filter activeClear all
What if we could print living tissue that functions inside the body?
Printing shapes is easy. Printing tissue that lives, breathes and connects is not.
5 Things You Need to Know About the Drug Approval Process
The FDA outlines key facts about how a new medicine moves from development to approval. It clarifies what regulators review and what an approval…
Explaining Clinical Trials
The European regulator explains what clinical trials are, why they are run in phases, and how participants are protected. A good baseline for reading…
NewLimit
Not publicly tradedNewLimit develops epigenetic reprogramming medicines intended to restore youthful function to aged cells, starting with liver cells. It was co-founded by Brian…
Altos Labs
Not publicly tradedAltos Labs studies cellular rejuvenation — resetting aspects of cell state to restore health and resilience. It has research sites in the…
Retro Biosciences
Not publicly tradedRetro Biosciences aims to extend healthy human lifespan through programs in autophagy, cell replacement and tissue reprogramming. Its lead oral drug, RTR242,…
Vertex Pharmaceuticals
Nasdaq: VRTXVertex develops small-molecule and genetic medicines for serious diseases and is best known for its cystic fibrosis drugs. It co-developed Casgevy, the…
insitro
Not publicly tradedinsitro, founded by Daphne Koller, combines machine learning with human cellular data to identify disease drivers and design drug candidates. It has…
Hyperfine
Nasdaq: HYPRHyperfine makes the Swoop system, a portable, ultra-low-field MRI scanner for brain imaging at the point of care. The company was founded…
GRAIL
Nasdaq: GRALGRAIL develops blood tests for early cancer detection; its Galleri multi-cancer early detection test is sold in the U.S. as a laboratory-developed…
Recursion Pharmaceuticals
Nasdaq: RXRXRecursion describes itself as a clinical-stage 'TechBio' company that combines automated biology and machine learning to find drug candidates. Its most advanced…
Illumina
Nasdaq: ILMNIllumina makes DNA sequencing instruments, reagents and software used widely in research and clinical genomics. It acquired GRAIL in 2021 and separated…